1. Home
  2. PRLD vs SHOT Comparison

PRLD vs SHOT Comparison

Compare PRLD & SHOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRLD
  • SHOT
  • Stock Information
  • Founded
  • PRLD 2016
  • SHOT 2018
  • Country
  • PRLD United States
  • SHOT United States
  • Employees
  • PRLD N/A
  • SHOT N/A
  • Industry
  • PRLD Medicinal Chemicals and Botanical Products
  • SHOT Biotechnology: Pharmaceutical Preparations
  • Sector
  • PRLD Health Care
  • SHOT Health Care
  • Exchange
  • PRLD Nasdaq
  • SHOT Nasdaq
  • Market Cap
  • PRLD 63.3M
  • SHOT 62.8M
  • IPO Year
  • PRLD 2020
  • SHOT 2020
  • Fundamental
  • Price
  • PRLD $1.04
  • SHOT $0.95
  • Analyst Decision
  • PRLD Buy
  • SHOT
  • Analyst Count
  • PRLD 3
  • SHOT 0
  • Target Price
  • PRLD $5.33
  • SHOT N/A
  • AVG Volume (30 Days)
  • PRLD 408.0K
  • SHOT 709.7K
  • Earning Date
  • PRLD 11-06-2024
  • SHOT 11-26-2024
  • Dividend Yield
  • PRLD N/A
  • SHOT N/A
  • EPS Growth
  • PRLD N/A
  • SHOT N/A
  • EPS
  • PRLD N/A
  • SHOT N/A
  • Revenue
  • PRLD $3,000,000.00
  • SHOT $180,174.00
  • Revenue This Year
  • PRLD N/A
  • SHOT N/A
  • Revenue Next Year
  • PRLD N/A
  • SHOT N/A
  • P/E Ratio
  • PRLD N/A
  • SHOT N/A
  • Revenue Growth
  • PRLD N/A
  • SHOT 68.01
  • 52 Week Low
  • PRLD $1.00
  • SHOT $0.55
  • 52 Week High
  • PRLD $6.80
  • SHOT $7.50
  • Technical
  • Relative Strength Index (RSI)
  • PRLD 21.69
  • SHOT 39.44
  • Support Level
  • PRLD $1.14
  • SHOT $0.91
  • Resistance Level
  • PRLD $1.36
  • SHOT $1.20
  • Average True Range (ATR)
  • PRLD 0.11
  • SHOT 0.09
  • MACD
  • PRLD 0.03
  • SHOT -0.01
  • Stochastic Oscillator
  • PRLD 7.53
  • SHOT 13.49

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.

About SHOT Safety Shot Inc.

Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.

Share on Social Networks: